This inventor holds 1 USPTO granted patent. Top assignee: Genentech, Inc.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Innovator Xiangnan Du: Pioneering Cancer Therapies
Introduction
Xiangnan Du is a notable inventor based in Fremont, California. He has made significant contributions to the field of medical therapies, particularly in the treatment of cancer. His innovative work focuses on the use of SCD1 antagonists, which have the potential to address various pathological conditions.
Latest Patents
Xiangnan Du holds 1 patent for his invention titled "Methods of using SCD1 antagonists." This patent outlines therapies aimed at treating cancer and describes methods for utilizing SCD1 antagonists effectively.
Career Highlights
Currently, Xiangnan Du is employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His work at Genentech has allowed him to further develop his research and contribute to advancements in cancer treatment.
Collaborations
Throughout his career, Xiangnan Du has collaborated with esteemed colleagues, including Avi J Ashkenazi and Jing Qing. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking therapies.
Conclusion
Xiangnan Du's contributions to the field of cancer therapies through his innovative use of SCD1 antagonists highlight his role as a significant inventor in the medical research community. His work continues to pave the way for new treatment options that could benefit many patients.